Corpus Intelligence IC Memo — DELTA COMMUNITY HOSPITAL 2026-04-26 04:03 UTC
IC Memo — DELTA COMMUNITY HOSPITAL
Investment Committee Memorandum | UT | 18 beds | Grade C | EBITDA uplift $1.1M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

DELTA COMMUNITY HOSPITAL

CCN 461300 | MILLARD, UT | 18 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

DELTA COMMUNITY HOSPITAL is a 18-bed suburban community hospital in MILLARD, UT with $15.2M in net patient revenue and a 5.3% operating margin. The hospital serves a payer mix of 26.5% Medicare, 24.6% Medicaid, and 48.9% commercial.

Thesis: Turnaround. Our ML models identify $1.1M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 5.3% to 12.6% (+736bps).

Net Revenue HCRIS$15.2M
Current EBITDA COMPUTED$796K
Operating Margin COMPUTED5.3%
Occupancy HCRIS10.0%
Revenue / Bed COMPUTED$842K
Net-to-Gross HCRIS60.6%
Distress Probability ML65.6%

2. Market Context & Competitive Position

59
UT Hospitals
8.0%
State Median Margin
20
Comparable Hospitals

UT has 59 Medicare-certified hospitals with a median operating margin of 8.0%. The target's margin of 5.3% places it below the state median. Among 20 size-comparable peers (9-36 beds), the median margin is -0.5%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (9-36), prioritizing same-state peers. 20 hospitals in the comp set.

HospitalStateBedsRevenueMargin
DELTA COMMUNITY HOSPITAL (Target)UT18$15.2M5.3%
GUNNISON VALLEY HOSPITALUT25$130.4M-6.4%
UINTAH BASIN MEDICAL CENTERUT33$119.9M1.8%
MOUNTAIN WEST MEDICAL CENTERUT36$96.1M38.5%
SPANISH FORK HOSPITALUT16$65.3M0.5%
CENTRAL VALLEY MEDICAL CENTERUT25$60.7M4.3%
SEVIER VALLEY HOSPITALUT24$58.2M14.5%
HEBER VALLEY HOSPITALUT19$55.8M8.4%
MOAB REGIONAL HOSPITALUT17$44.2M-3.4%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $1.1M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$318K+210bp18mo
Cost to Collect4.5%2.5%$303K+200bp12mo
Denial Rate Reduction12.0%6.5%$300K+198bp12mo
A/R Days Reduction5200.0%3800.0%$184K+122bp9mo
Clean Claim Rate88.0%96.0%$10K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$318K
Cost to Collect
$303K
Denial Rate Reduction
$300K
A/R Days Reduction
$184K
Clean Claim Rate
$10K
Total EBITDA Uplift$1.1M
Current EBITDA$796K
+ RCM Uplift+$1.1M
Pro Forma EBITDA$1.9M
Current Margin5.3%
Pro Forma Margin12.6%
WC Released (1x)$581K

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$1.2M$16.4M13.39x68.0%
Base (11x exit)10.0x11.0x$1.2M$18.4M15.05x72.0%
Bull Case9.0x11.0x$1.1M$22.5M20.43x82.8%
Bull (12x exit)9.0x12.0x$1.1M$24.9M22.58x86.5%
Bear Case11.0x10.0x$1.3M$10.4M7.74x50.6%
Bear (11x exit)11.0x11.0x$1.3M$11.9M8.84x54.6%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
MediumElevated Medicaid exposure (24.6%)Medicaid reimburses below cost in most states. Mitigant: denial reduction lever has highest impact on Medicaid claims
MediumLow occupancyAt 10.0%, fixed costs are spread over fewer patient days. Mitigant: volume growth is an additional upside lever not modeled in base case
HighElevated distress probabilityModel estimates 65.6% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 20 hospitals with 9-36 beds
  • Same-state prioritization (n=21)
  • Comp margins: P25=-9.2% / P50=-0.5% / P75=5.8%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.